^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SBI-726

    i
    Other names: SBI-726

    Associations

    News
    Trials
    Company:
    National Cancer Institute - Bethesda, Sanford-Burnham Medical Research Institute, TGen
    Drug class:
    AKT inhibitor, mTORC1 inhibitor, NF-κB inhibitor, eIF4G1 inhibitor
    Related drugs:

    Associations

    News
    Trials